We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Express Scripts, Others Face ERISA Suit Over EpiPen Costs

Law360, New York (August 29, 2017, 4:09 PM EDT) -- Pharmacy benefit managers Express Scripts Inc., OptumRx Inc. and Prime Therapeutics LLC have agreed to give Mylan Pharmaceuticals Inc.’s EpiPen favorable placement on drug formularies in exchange for kickbacks, employees under...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.